The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Gemfeibrozil vs simvastatin in treating diabetic hyperlipidemia and affecting hemorheology
Author(s): 
Pages: 406-408
Year: Issue:  6
Journal: CHINESE JOURNAL OF NEW DRUGS AND CLINICAL REMEDIES

Keyword:  吉非罗齐辛伐他汀高脂血症血液流变学;
Abstract: 目的:比较吉非罗齐与辛伐他汀治疗糖尿病高脂血症疗效及对血液流变学的影响.方法:吉非罗齐组36例(男性16例,女性20例,年龄61 a±s11 a),给吉非罗齐300 mg,bid×45 d;辛伐他汀组32例(男性13例,女性19例,年龄63 a±10 a),给辛伐他汀20 mg,qd×45 d.结果:2组降胆固醇有效率分别为56%,72%(P>0.05),降三酰甘油有效率分别为89%,50%(P<0.05),升高密度脂蛋白胆固醇有效率分别为53%,47%(P>0.05),用吉非罗齐后凝血因子Ι显著下降(P<0.01).2组不良反应轻微.结论:吉非罗齐与辛伐他汀调脂作用肯定,吉非罗齐降三酰甘油的作用优于辛伐他汀,能改善血粘度,并且安全.
Related Articles
loading...